Octapharma AG - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Octapharma AG (Octapharma) is a human protein manufacturer that focuses on developing and producing human proteins from human plasma and cell lines. The company treats patients worldwide with products across immunotherapy (immune disorders), haematology (coagulation disorders), and critical care therapeutic areas. It sources majority of plasma from company-owned donation centers. Octapharma owns plasma donation centers in the USA and in Germany, and owns six state-of-the-art production facilities in Austria, Germany, France, Mexico and Sweden. The companys production plants carry out plasma fractionation and purification, pharmaceutical production, research and development, product labelling, packaging, storage and distribution. Octapharma is headquartered in Lachen, Switzerland.

Octapharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Octapharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Octapharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Octapharma AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Octapharma Enters Into Co-Marketing Agreement With Pfizer 10
Licensing Agreements 11
Hikma Pharma Enters into Licensing Agreement with Octapharma 11
Octapharma Enters into Licensing Agreement with Glycotope 12
Equity Offering 13
Glycotope to Raise USD90 Million in Private Placement of Shares 13
Octapharma AG - Key Competitors 14
Octapharma AG - Key Employees 15
Octapharma AG - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 19
Financial Announcements 19
Mar 01, 2018: Octapharma Group publishes 2017 annual results reporting revenue of 1.72 billion and operating income of 349 million 19
Mar 01, 2017: Octapharma Group Publishes 2016 Annual Results Reporting Revenue of 1.6 Billion and Operating Income of 383 Million 20
Product News 21
May 28, 2018: Octapharma present new data on the benefits of Nuwiq in patients with haemophilia A at the World Federation of Hemophilia 2018 World Congress 21
Clinical Trials 22
May 28, 2018: Octapharma share promising preclinical data for SubQ-8, a novel subcutaneous recombinant FVIII, at WFH 2018 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List Of Tables


Octapharma AG, Pharmaceuticals & Healthcare, Key Facts 2
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Octapharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Octapharma AG, Deals By Therapy Area, 2012 to YTD 2018 8
Octapharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Octapharma Enters Into Co-Marketing Agreement With Pfizer 10
Hikma Pharma Enters into Licensing Agreement with Octapharma 11
Octapharma Enters into Licensing Agreement with Glycotope 12
Glycotope to Raise USD90 Million in Private Placement of Shares 13
Octapharma AG, Key Competitors 14
Octapharma AG, Key Employees 15
Octapharma AG, Other Locations 16
Octapharma AG, Subsidiaries 16

List Of Figures


Octapharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Octapharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Octapharma AG - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Octapharma AG (Octapharma) is a human protein manufacturer that focuses on developing and producing human proteins from human plasma and cell lines. The company treats patients worldwide with products across

USD 250 View Report

Octapharma AG Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Octapharma AG Company Profile is a detailed strategic and analytical report on Octapharma AG. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

SoftwareONE Holding AG - Strategic SWOT Analysis Review

SoftwareONE Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Marquard & Bahls AG - Strategic SWOT Analysis Review

Marquard & Bahls AG - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available